In murine models, butyrate activates nicotinic acid receptor 1, downregulates amyloid precursor protein expression, and upregulates AD-related proteins such as nephronectin and BDNF, effectively reversing Aβ-induced damage in neuroblastoma cells (Sun et al., 2020). Here, APP is linked to Alzheimer disease.